Focuses on core financial concepts within the pharmaceutical industry, emphasizing their application for strategic decision-making and effective collaboration between commercial and finance teams. Key topics include Net Present Value (NPV) and Risk-Adjusted Net Present Value (rNPV) for evaluating drug candidates, Internal Rate of Return (IRR) for assessing investment profitability, and the Weighted Average Cost of Capital (WACC). The texts also explain Discounted Cash Flow (DCF) analysis for valuation, methods for building robust business cases for pipeline assets, and strategies for translating commercial insights into financial language to foster better partnership. Overall, the documents aim to enhance financial literacy for commercial professionals to improve resource allocation and portfolio optimization in the high-risk pharmaceutical sector.